Signaling pathway dysregulation in breast cancer

Area of Science:

• Oncology
• Molecular Biology
• Biochemistry

Background:

• Breast cancer (BC) is a leading cause of cancer mortality in women globally.
• Dysregulated cellular signaling pathways are central to BC development, progression, and treatment resistance.

Purpose of the Study:

• To comprehensively analyze signaling pathways in breast cancer.
• To explore the role of protein complex structural dynamics in signaling regulation.
• To identify therapeutic strategies targeting these pathways and the impact of mutations.

Main Methods:

• Review of existing literature on breast cancer signaling pathways.
• Analysis of structural dynamics of protein complexes involved in signaling cascades.
• Examination of alterations across BC subtypes and mutation-specific impacts.

Main Results:

• Signaling pathway dysregulation drives tumor growth and treatment resistance in BC.
• Specific mutations influence therapeutic decisions and BC subtype characteristics.
• Approved and investigational therapies target disrupted signaling pathways.

Conclusions:

• Targeting aberrant signaling pathways offers promising therapeutic avenues for breast cancer.
• Personalized treatment approaches require further elucidation of underlying mechanisms and mutation relevance.
• Understanding protein complex dynamics is crucial for optimizing BC therapies.